Xiaoli Ma

491 total citations
30 papers, 290 citations indexed

About

Xiaoli Ma is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Xiaoli Ma has authored 30 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 13 papers in Public Health, Environmental and Occupational Health and 8 papers in Molecular Biology. Recurrent topics in Xiaoli Ma's work include Acute Myeloid Leukemia Research (15 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Acute Lymphoblastic Leukemia research (13 papers). Xiaoli Ma is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Acute Lymphoblastic Leukemia research (13 papers). Xiaoli Ma collaborates with scholars based in China and United States. Xiaoli Ma's co-authors include Yang Zhang, Xue Chen, Hongxing Liu, Panxiang Cao, Fang Wang, Wen Teng, Yu Zhang, Jiaqi Chen, Mingyu Wang and Jiancheng Fang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer.

In The Last Decade

Xiaoli Ma

28 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoli Ma China 10 150 104 74 56 49 30 290
Lisandro Ribeiro Brazil 9 105 0.7× 93 0.9× 43 0.6× 24 0.4× 24 0.5× 23 265
Sigrid Machherndl‐Spandl Austria 8 159 1.1× 87 0.8× 30 0.4× 23 0.4× 63 1.3× 36 248
Masamune Higashigawa Japan 11 97 0.6× 136 1.3× 62 0.8× 66 1.2× 43 0.9× 55 355
Sushrut Patil Australia 10 98 0.7× 68 0.7× 33 0.4× 78 1.4× 61 1.2× 35 292
Nattee Narkbunnam Thailand 8 77 0.5× 137 1.3× 41 0.6× 42 0.8× 46 0.9× 20 321
Maddalena Migliavacca Italy 10 130 0.9× 72 0.7× 51 0.7× 27 0.5× 25 0.5× 12 308
Anna Castleton United Kingdom 9 80 0.5× 88 0.8× 93 1.3× 24 0.4× 40 0.8× 18 305
Nicole Raus France 10 183 1.2× 42 0.4× 54 0.7× 27 0.5× 33 0.7× 23 259
Manuela Testi Italy 13 241 1.6× 67 0.6× 57 0.8× 55 1.0× 165 3.4× 23 479
Michelle DeVeaux United States 8 59 0.4× 94 0.9× 21 0.3× 31 0.6× 55 1.1× 14 248

Countries citing papers authored by Xiaoli Ma

Since Specialization
Citations

This map shows the geographic impact of Xiaoli Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Ma more than expected).

Fields of papers citing papers by Xiaoli Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Ma. The network helps show where Xiaoli Ma may publish in the future.

Co-authorship network of co-authors of Xiaoli Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Ma. A scholar is included among the top collaborators of Xiaoli Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Ma. Xiaoli Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Deyan, Jiaqi Chen, Yu Luo, et al.. (2025). Clinical features and fusion gene analysis of two Torque Teno Mini virus associated acute promyelocytic leukemia cases. Annals of Hematology. 104(8). 4251–4255.
3.
Zhou, Xiaosu, Xue Chen, Jiaqi Chen, et al.. (2023). The Ingenious Multiple Efficacies of the Integrated Gene Fragment of Torque Teno Mini Virus in Orchestrating Promyelocytic Leukemogenesis Via Hijacking Rara. Blood. 142(Supplement 1). 1576–1576. 2 indexed citations
4.
Liu, Yang, Tong Wang, Hui Wang, et al.. (2022). Competitive evolved sub‐clonal BCR::ABL1 and novel MSI2:: PC fusion genes in myelodysplastic syndrome with isolated del(5q). Hematological Oncology. 41(1). 178–181. 2 indexed citations
5.
Chen, Xue, Fang Wang, Yang Zhang, et al.. (2021). Fusion gene map of acute leukemia revealed by transcriptome sequencing of a consecutive cohort of 1000 cases in a single center. Blood Cancer Journal. 11(6). 112–112. 32 indexed citations
6.
Zhang, Jing, Fang Wang, Lili Liu, et al.. (2021). Fanconi anemia gene-associated germline predisposition in aplastic anemia and hematologic malignancies. Frontiers of Medicine. 16(3). 459–466. 5 indexed citations
7.
Zhang, Yang, Fang Wang, Xue Chen, et al.. (2021). Next‐generation sequencing reveals the presence of DDX41 mutations in acute lymphoblastic leukemia and aplastic anemia. SHILAP Revista de lepidopterología. 2(3). 508–513. 10 indexed citations
8.
Wang, Hainan, et al.. (2021). Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report. Brazilian Journal of Medical and Biological Research. 54(12). e11605–e11605. 2 indexed citations
10.
Wang, Tong, Xue Chen, Ying Yin, et al.. (2020). Ectopia associated MN1 fusions and aberrant activation in myeloid neoplasms with t(12;22)(p13;q12). Cancer Gene Therapy. 27(10-11). 810–818. 11 indexed citations
11.
Ma, Zhuo, Yue‐He Ding, Xiaoli Ma, et al.. (2020). Epidemiological and clinical characteristics of discharged patients infected with SARS‐CoV‐2 on the Qinghai Plateau. Journal of Medical Virology. 92(11). 2528–2535. 21 indexed citations
12.
Zhang, Jing, Fang Wang, Wei Zhang, et al.. (2020). Comprehensive analysis on phenotype and genetic basis of Chinese Fanconi anemia patients: dismal outcomes call for nationwide studies. BMC Medical Genetics. 21(1). 118–118. 5 indexed citations
13.
Liu, Hongxing, Jiaqi Chen, Fang Wang, et al.. (2020). NGS-Based Screening to Comprehensively Decipher TKIs Resistant Mutations in BCR-ABL1 Positive Leukemias. Blood. 136(Supplement 1). 30–30. 2 indexed citations
14.
15.
Chen, Jiaqi, Hongxing Liu, Fang Wang, et al.. (2019). Dynamic Evolution of Ponatinib Resistant BCR-ABL1 T315 and Compound Mutations. Blood. 134(Supplement_1). 3796–3796. 3 indexed citations
16.
Zhang, Yu, Yang Zhang, Fang Wang, et al.. (2019). The mutational spectrum of FLT3 gene in acute lymphoblastic leukemia is different from acute myeloid leukemia. Cancer Gene Therapy. 27(1-2). 81–88. 18 indexed citations
17.
Zhang, Yang, Fang Wang, Xue Chen, et al.. (2019). Companion gene mutations and their clinical significance in AML with double mutant CEBPA. Cancer Gene Therapy. 27(7-8). 599–606. 19 indexed citations
18.
Zhang, Yang, Fang Wang, Xue Chen, et al.. (2018). CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia. Cancer. 124(16). 3329–3338. 37 indexed citations
19.
Chen, Xue, Fang Wang, Yang Zhang, et al.. (2018). Retrospective analysis of 36 fusion genes in 2479 Chinese patients of de novo acute lymphoblastic leukemia. Leukemia Research. 72. 99–104. 21 indexed citations
20.
Wang, Yunshan, Hong Shen, Lihua Jiang, et al.. (2004). Cross-reaction of SARS-CoV antigen with autoantibodies in autoimmune diseases.. PubMed. 1(4). 304–7. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026